Geron (GERN) EBT Margin (QoQ) (2010 - 2026)
Powered by 
Analysis
Geron (GERN) EBT Margin (QoQ) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Geron | 914.60 Mn | 613.75 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2,212.00 |
| Mar 31, 2026 | 2,612.00 |
| Dec 31, 2025 | 568.00 |
| Sep 30, 2025 | -541.00 |
| Jun 30, 2025 | 1,661.00 |
| Mar 31, 2025 | -1,052.00 |
| Dec 31, 2024 | 5,397.00 |
| Sep 30, 2024 | 753,933.00 |
| Jun 30, 2024 | 1.06 Mn |
| Mar 31, 2024 | 20.79 Mn |
| Dec 31, 2023 | -19.89 Mn |
| Sep 30, 2023 | 14.24 Mn |
| Jun 30, 2023 | 1.20 Mn |
| Mar 31, 2023 | -14.02 Mn |
| Dec 31, 2022 | -2.77 Mn |
| Sep 30, 2022 | 2.63 Mn |
| Jun 30, 2022 | -1.51 Mn |
| Mar 31, 2022 | -2.19 Mn |
| Dec 31, 2021 | 2.13 Mn |
| Sep 30, 2021 | 320,135.00 |